SynBioBeta Speaker

Kerri Dugan

Applied Research Institute

SVP Biotech

Dr. Kerri Dugan is the Senior Vice President for Biotechnology at Applied Research Institute. Her experience includes transitioning capabilities across broad multi-disciplinary domains including biotechnology, geospatial intelligence, forensic science and critical technology areas in support of national security. She held leadership positions at DARPA, National Geospatial-Intelligence Agency, the National Science Foundation, and Federal Bureau of Investigation Laboratory Division. She holds a PhD in molecular biology from Princeton University.

Sessions Featuring

Kerri

This Year

Breakout Session

โ€ข

4:30 PM

-

5:15 PM

Business of Biology

Bio-Ready America: Advancing Bioliteracy to Power the U.S. Bioeconomy

As the U.S. accelerates into the age of biotechnology, the future of our national competitiveness, economic growth, and security depend on a workforce and citizenry fluent in biotechnology. This panel brings together leaders to explore how bioliteracy and a biotech-ready workforce can become strategic assets to power the U.S. bioeconomy.

Featuring

Drew Endy

Stanford University

Hoover Inst Fellow

Synthetic biology pioneer, co-founded iGEM and BioBricks.

Amy Jenkins

AstraZeneca

Sr Dir, Strat & Ops

Pandemic-response biotech leader; built rapid antibody platforms.

Stuart Sevier

IMI

President

Physicist turned science-media trust builder amplifying research stories.

Maria Thacker-Goethe

Georgia Life Sciences

President & CEO

Alexander Titus

NSCEB

Commissioner

Kerri Dugan

Applied Research Institute

SVP Biotech

Breakout Session

โ€ข

4:30 PM

-

5:15 PM

Business of Biology

Bio-Ready America: Advancing Bioliteracy to Power the U.S. Bioeconomy

As the U.S. accelerates into the age of biotechnology, the future of our national competitiveness, economic growth, and security depend on a workforce and citizenry fluent in biotechnology. This panel brings together leaders to explore how bioliteracy and a biotech-ready workforce can become strategic assets to power the U.S. bioeconomy.

Featuring

Drew Endy

Stanford University

Hoover Inst Fellow

Synthetic biology pioneer, co-founded iGEM and BioBricks.

Amy Jenkins

AstraZeneca

Sr Dir, Strat & Ops

Pandemic-response biotech leader; built rapid antibody platforms.

Stuart Sevier

IMI

President

Physicist turned science-media trust builder amplifying research stories.

Maria Thacker-Goethe

Georgia Life Sciences

President & CEO

Alexander Titus

NSCEB

Commissioner

Kerri Dugan

Applied Research Institute

SVP Biotech

Previous Speakers Include